This schedule indicates the recommended ages for routine administration
of currently licensed childhood vaccines, as of December 1, 2006, for
children aged 06 years. Additional information is available at http://www.cdc.gov/nip/recs/child-schedule.htm. Any dose not administered at the recommended age should be administered at any subsequent visit, when indicated and feasible. Additional vaccines may be licensed and recommended during the year. Licensed combination vaccines may be used whenever any components of the combination are indicated and other components of the vaccine are not contraindicated and if approved by the Food and Drug Administration for that dose of the series. Providers should consult the respective Advisory Committee on Immunization Practices statement for detailed recommendations. Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and complete a VAERS form is available at http://www.vaers.hhs.gov or by telephone, 800-822-7967. FOOTNOTES ON REVERSE SIDE Department of Health and Human Services Centers for Disease Control and Prevention Recommended Immunization Schedule for Persons Aged 06 YearsUNITED STATES 2007 Catch-up immunization Certain high-risk groups Range of recommended ages The Recommended Immunization Schedules for Persons Aged 018 Years are approved by: Advisory Committee on Immunization Practices (http://www.cdc.gov/nip/acip) American Academy of Pediatrics (http://www.aap.org) American Academy of Family Physicians (http://www.aafp.org) More information regarding vaccine administration can be obtained from the websites above or the CDC-INFO contact center: 800-CDC-INFO ENGLISH & ESPAOL 24/7 [800-232-4636] Keep track of your childs immunizations with the CDC Childhood Immunization Scheduler www.cdc.gov/nip/kidstuff/scheduler.htm Vaccine Age Birth 1 month 2 months 4 months 6 months 12 months 15 months 18 months 1923 months 23 years 46 years Hepatitis B 1 Rotavirus 2 Diphtheria, Tetanus, Pertussis 3 Haemophilus influenzae type b 4 Pneumococcal 5 Inactivated Poliovirus Influenza 6 Measles, Mumps, Rubella 7 Varicella 8 Hepatitis A 9 Meningococcal 10 HepB Series HepB HepB HepB see footnote1 DTaP DTaP DTaP Rota Rota Rota DTaP DTaP Hib Hib Hib 4 Hib IPV IPV IPV IPV MMR MMR Varicella Varicella PCV Hib PPV PCV PCV PCV PCV Influenza (Yearly) HepA (2 doses) MPSV4 HepA Series 07childhoodschedule-0-6years_6x4.5.qxp 2/26/2007 2:33 PM Page 1 FOOTNOTES 1. Hepatitis B vaccine (HepB). (Minimum age: birth) At birth: Administer monovalent HepB to all newborns before hospital discharge. If mother is hepatitis surface antigen (HBsAg)-positive, administer HepB and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth. If mothers HBsAg status is unknown, administer HepB within 12 hours of birth. Determine the HBsAg status as soon as possible and if HBsAg-positive, administer HBIG (no later than age 1 week). If mother is HBsAg-negative, the birth dose can only be delayed with physicians order and mothers negative HBsAg laboratory report documented in the infants medical record. After the birth dose: The HepB series should be completed with either monovalent HepB or a combination vaccine containing HepB. The second dose should be administered at age 12 months. The final dose should be admin- istered at age 24 weeks. Infants born to HBsAg-positive mothers should be tested for HBsAg and antibody to HBsAg after completion of 3 doses of a licensed HepB series, at age 918 months (generally at the next well-child visit). 4-month dose: It is permissible to administer 4 doses of HepB when combination vaccines are administered after the birth dose. If monovalent HepB is used for doses after the birth dose, a dose at age 4 months is not needed. 2. Rotavirus vaccine (Rota). (Minimum age: 6 weeks) Administer the first dose at age 612 weeks. Do not start the series later than age 12 weeks. Administer the final dose in the series by age 32 weeks. Do not administer a dose later than age 32 weeks. Data on safety and efficacy outside of these age ranges are insufficient. 3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). (Minimum age: 6 weeks) The fourth dose of DTaP may be administered as early as age 12 months, provided 6 months have elapsed since the third dose. Administer the final dose in the series at age 46 years. 4. Haemophilus influenzae type b conjugate vaccine (Hib). (Minimum age: 6 weeks) If PRP-OMP (PedvaxHIB
or ComVax
[Merck]) is administered at ages
2 and 4 months, a dose at age 6 months is not required. TriHiBit
(DTaP/Hib) combination products should not be used for
primary immunization but can be used as boosters following any Hib vaccine in children aged 12 months. 5. Pneumococcal vaccine. (Minimum age: 6 weeks for pneumococcal conjugate vaccine [PCV]; 2 years for pneumococcal polysaccharide vaccine [PPV]) Administer PCV at ages 2459 months in certain high-risk groups. Administer PPV to children aged 2 years in certain high-risk groups. See MMWR 2000;49(No. RR-9):135. 6. Influenza vaccine. (Minimum age: 6 months for trivalent inactivated influenza vaccine [TIV]; 5 years for live, attenuated influenza vaccine [LAIV]) All children aged 659 months and close contacts of all children aged 059 months are recommended to receive influenza vaccine. Influenza vaccine is recommended annually for children aged 59 months with certain risk factors, health-care workers, and other persons (including household members) in close contact with persons in groups at high risk. See MMWR 2006;55(No. RR-10):141. For healthy persons aged 549 years, LAIV may be used as an alternative to TIV. Children receiving TIV should receive 0.25 mL if aged 635 months or 0.5 mL if aged 3 years. Children aged <9 years who are receiving influenza vaccine for the first time should receive 2 doses (separated by 4 weeks for TIV and 6 weeks for LAIV). 7. Measles, mumps, and rubella vaccine (MMR). (Minimum age: 12 months) Administer the second dose of MMR at age 46 years. MMR may be administered before age 46 years, provided 4 weeks have elapsed since the first dose and both doses are administered at age 12 months. 8. Varicella vaccine. (Minimum age: 12 months) Administer the second dose of varicella vaccine at age 46 years. Varicella vaccine may be administered before age 46 years, provided that 3 months have elapsed since the first dose and both doses are administered at age 12 months. If second dose was administered 28 days following the first dose, the second dose does not need to be repeated. 9. Hepatitis A vaccine (HepA). (Minimum age: 12 months) HepA is recommended for all children aged 1 year (i.e., aged 1223 months). The 2 doses in the series should be administered at least 6 months apart. Children not fully vaccinated by age 2 years can be vaccinated at subsequent visits. HepA is recommended for certain other groups of children, including in areas where vaccination programs target older children. See MMWR 2006;55(No. RR-7):123. 10. Meningococcal polysaccharide vaccine (MPSV4). (Minimum age: 2 years) Administer MPSV4 to children aged 210 years with terminal complement deficiencies or anatomic or functional asplenia and certain other high-risk groups. See MMWR 2005;54(No. RR-7):121. CS108190 07childhoodschedule-0-6years_6x4.5.qxp 2/26/2007 2:33 PM Page 2